L. Mesin, J. Ersching, and G. D. Victora, Germinal center B cell dynamics. Immunity, vol.45, pp.471-482, 2016.

F. Weisel and M. Shlomchik, Memory B cells of mice and humans, Annu. Rev. Immunol, vol.35, pp.255-284, 2017.

J. J. Taylor, M. K. Jenkins, and K. A. Pape, Heterogeneity in the differentiation and function of memory B cells, Trends Immunol, vol.33, pp.590-597, 2012.

A. H. Ellebedy, Defining antigen-specific plasmablast and memory B cell subsets in human blood after viral infection or vaccination, Nat. Immunol, vol.17, pp.1226-1234, 2016.

D. Lau, Low CD21 expression defines a population of recent germinal center graduates primed for plasma cell differentiation, Sci. Immunol, vol.2, p.8153, 2017.

S. F. Andrews, Activation dynamics and immunoglobulin evolution of preexisting and newly generated human memory B cell responses to influenza hemagglutinin, Immunity, vol.51, 2019.

G. V. Zuccarino-catania, CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype, Nat. Immunol, vol.15, pp.631-637, 2014.

K. A. Pape, Naive B cells with high-avidity germline-encoded antigen receptors produce persistent IgM(+) and transient IgG(+) memory B cells, Immunity, vol.48, p.4, 2018.

K. A. Pape, J. J. Taylor, R. W. Maul, P. J. Gearhart, and M. K. Jenkins, Different B cell populations mediate early and late memory during an endogenous immune response, Science, vol.331, pp.1203-1207, 2011.

I. Dogan, Multiple layers of B cell memory with different effector functions, Nat. Immunol, vol.10, pp.1292-1299, 2009.

R. A. Mason, N. M. Tauraso, R. O. Spertzel, and R. K. Ginn, Yellow fever vaccine: Direct challenge of monkeys given graded doses of 17D vaccine, Appl. Microbiol, vol.25, pp.539-544, 1973.

O. Vratskikh, Dissection of antibody specificities induced by yellow fever vaccination, PLoS Pathog, vol.9, p.1003458, 2013.

X. Lu, Double lock of a human neutralizing and protective monoclonal antibody targeting the yellow fever virus envelope, Cell Rep, vol.26, p.5, 2019.

S. Daffis, Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: Characterization with human monoclonal antibody fragments and neutralization escape variants, Virology, vol.337, pp.262-272, 2005.

R. W. Wieten, A single 17D yellow fever vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody and T-cell responses after vaccination, PLoS One, vol.11, p.149871, 2016.

N. P. Lindsey, Persistence of yellow fever virus-specific neutralizing antibodies after vaccination among US travellers, J. Travel Med, vol.25, p.108, 2018.

S. Kohler, The early cellular signatures of protective immunity induced by live viral vaccination, Eur. J. Immunol, vol.42, pp.2363-2373, 2012.

M. S. Gilman, Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors, Sci. Immunol, vol.1, p.1879, 2016.

R. and D. Niro, Salmonella infection drives promiscuous B cell activation followed by extrafollicular affinity maturation, Immunity, vol.43, pp.120-131, 2015.

W. Dejnirattisai, A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus, Nat. Immunol, vol.16, pp.170-177, 2015.

J. Wrammert, Rapid cloning of high-affinity human monoclonal antibodies against influenza virus, Nature, vol.453, pp.667-671, 2008.

B. Reinhardt, R. Jaspert, M. Niedrig, C. Kostner, and J. L'age-stehr, Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: A model of human flavivirus infection, J. Med. Virol, vol.56, pp.159-167, 1998.

W. D. Crill and G. J. Chang, Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes, J. Virol, vol.78, pp.13975-13986, 2004.

A. Sivasubramanian, Broad epitope coverage of a human in vitro antibody library, MAbs, vol.9, pp.29-42, 2017.

E. N. Gallichotte, Role of Zika virus envelope protein domain III as a target of human neutralizing antibodies, MBio, vol.10, pp.1485-1504, 2019.

C. H. Calisher, Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera, J. Gen. Virol, vol.70, pp.37-43, 1989.

K. L. Mansfield, Flavivirus-induced antibody cross-reactivity, J. Gen. Virol, vol.92, pp.2821-2829, 2011.

L. Priyamvada, Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus, Proc. Natl. Acad. Sci. U.S.A, vol.113, pp.7852-7857, 2016.

T. P. Monath, Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial, Am. J. Trop. Med. Hyg, vol.66, pp.533-541, 2002.

J. Lang, Comparison of the immunogenicity and safety of two 17D yellow fever vaccines, Am. J. Trop. Med. Hyg, vol.60, pp.1045-1050, 1999.

J. J. Taylor, K. A. Pape, H. R. Steach, and M. K. Jenkins, Apoptosis and antigen affinity limit effector cell differentiation of a single naïve B cell, Humoral immunity, vol.347, pp.784-787, 2015.

D. Paus, Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation, J. Exp. Med, vol.203, pp.1081-1091, 2006.

S. Crotty, Cutting edge: Long-term B cell memory in humans after smallpox vaccination, J. Immunol, vol.171, pp.4969-4973, 2003.

B. A. Heesters, Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation, Immunity, vol.38, pp.1164-1175, 2013.

B. A. Smith, Persistence of infectious HIV on follicular dendritic cells, J. Immunol, vol.166, pp.690-696, 2001.

B. A. Heesters, R. C. Myers, and M. C. Carroll, Follicular dendritic cells: Dynamic antigen libraries, Nat. Rev. Immunol, vol.14, pp.495-504, 2014.

J. G. Tew and T. E. Mandel, Prolonged antigen half-life in the lymphoid follicles of specifically immunized mice, Immunology, vol.37, pp.69-76, 1979.

C. W. Davis, Longitudinal analysis of the human B cell response to Ebola virus infection, Cell, vol.177, pp.1566-1582, 2019.

K. Matsuda, Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine, Sci. Immunol, vol.4, p.2710, 2019.

I. J. Amanna, N. E. Carlson, and M. K. Slifka, Duration of humoral immunity to common viral and vaccine antigens, N. Engl. J. Med, vol.357, pp.1903-1915, 2007.

A. Lanzavecchia, Dissecting human antibody responses: Useful, basic and surprising findings, EMBO Mol. Med, vol.10, p.8879, 2018.

B. Briney, A. Inderbitzin, C. Joyce, and D. R. Burton, Commonality despite exceptional diversity in the baseline human antibody repertoire, Nature, vol.566, pp.393-397, 2019.

N. D. Collins and A. D. Barrett, Live attenuated yellow fever 17D vaccine: A legacy vaccine still controlling outbreaks in modern day, Curr. Infect. Dis. Rep, vol.19, p.14, 2017.

M. J. Luppe, Yellow fever (YF) vaccination does not increase dengue severity: A retrospective study based on 11,448 dengue notifications in a YF and dengue endemic region, Travel Med. Infect. Dis, vol.30, pp.25-31, 2019.

T. Tiller, Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning, J. Immunol. Methods, vol.329, pp.112-124, 2008.

A. Kovaltsuk, Observed antibody space: A resource for data mining nextgeneration sequencing of antibody repertoires, J. Immunol, vol.201, pp.2502-2509, 2018.